Search

Orthocell considers IPO push

Biotech player Orthocell has appointed two financial advisory firms to seek out investors as part of the company’s plans to go public.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Orthocell (OCC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 30/11/18

1 year TSR5 year TSR
560thHazer Group-39%0%
595thOrthocell-45%0%
633rdPointerra-50%-20%
835thSkin Elements-87%0%
741 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

09/05/18
$17k Issued
09/05/18
$20k Issued
09/05/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

162nd↓Orthocell$884k
163rd-Ocean Grown Abalone$844k
164th-Skin Elements$838k
166th↑Pointerra$799k
167th↑Hazer Group$759k
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer